►
From YouTube: Panel Discussion: Best Practices From Leading Healthcare and Life Sciences Blockchain Production...
Description
Panel Discussion: Best Practices From Leading Healthcare and Life Sciences Blockchain Production Deployments and Advanced Research Investigations - Sophia Lopez, kaleido.io; Flora Nanda, Pfizer Digital; Alan Bachmann; Jim St. Clair, LF Public Health
Speakers: Alan Bachmann, Flora Nanda, Sophia Lopez
This session will share the industry best practices and lessons learned across healthcare and life sciences enterprise consortia for building and governance, reference architectures, usability, management, and operation.
Sessions Details & Slides (if available): https://sched.co/14H6Y
Access All Sessions: https://events.linuxfoundation.org/hyperledger-global-forum/program/schedule/
----
Hyperledger – Open Source Blockchain Technologies
Hyperledger is an open source community focused on developing a suite of stable frameworks, tools and libraries for enterprise-grade blockchain deployments.
It serves as a neutral home for various distributed ledger frameworks including Hyperledger Besu, Fabric, Sawtooth, Indy, as well as tools like Hyperledger Avalon, Cactus and libraries like Hyperledger Aries, Ursa. Learn more about Hyperledger projects: https://www.hyperledger.org/use
Discord: https://discord.gg/rVCn4j7UFd
Case Studies: https://www.hyperledger.org/learn/case-studies
Training & Certification: https://www.hyperledger.org/learn/training
Tutorials: https://www.hyperledger.org/use/tutorials
Webinars: https://www.hyperledger.org/learn/webinars
Events: https://www.hyperledger.org/events
Vendor Directory: https://www.hyperledger.org/use/vendor-directory
Subscribe to the Hyperledger Newsletter: https://www.hyperledger.org/newsletter
Follow-us on Twitter @Hyperledger
Learn about Hyperledger Membership: https://www.hyperledger.org/about/join
#Hyperledger #Blockchain
License
Creative Commons Attribution license (reuse allowed)
A
Good
afternoon,
everyone
and
welcome
to
the
really
long
title:
that's
around
blockchain
and
Healthcare.
My
name
is
Jim
Sinclair
I'm,
the
executive
director
for
Linux,
Foundation,
Public,
Health
and
I'm
very
pleased
to
have
four
of
my
friends
here
today
to
talk
about
both
Healthcare
as
an
industry
and
Life
Sciences,
as
well
as
implications
for
blockchain
and
I.
Think
just
get
into
some
of
the
details.
A
A
great
question,
perhaps
supposed
everyone
is
there?
Anyone
here
that
comes
from
a
healthcare
background
or
associated
with
Healthcare
Life
Sciences
in
your
business
practice,
great
fantastic
one,
two
three
yeah!
This
is
great.
The
numbers
are
building
four
got
a
good
one,
you're
outstanding
good
good
five
I
said
five
snuck
in
there
do
I
get
six
I
want
six.
Everybody
got
six
on
the
floor.
A
Yeah
it's
gonna,
be
a
good
time,
absolutely
well
great!
Well,
so
this
is
intended
to
be
informative
as
much
about
the
Wild
and
Wacky
World
of
Health
Care
and
Life
Sciences,
which
are
commonly
associated
with
one
another,
but
really
constitute
huge
Industries
on
their
own
and
then,
of
course,
those
aspects
of
blockchain
from
an
architecture
or
from
a
decentralization
from
a
business
standpoint
with
that
I'm
going
to
turn
it
over.
Excuse
me
to
my
panelists
in
La
Florida,
introduce
herself
and
pass
the
mic
down
and
and
talk
to
everybody.
Okay,.
B
Thank
you,
Jim
hi,
everyone,
nice
to
see
you
all.
My
name
is
Flora
Nanda
I'm
from
faiso
I
am
the
technology
and
process
lead
for
Pfizer
and
one
of
the
main
focus
technology
areas
is
blockchain,
so
we
have
like
different
projects.
We
are
part
of
different
Consortium,
which
are
our
external
initiatives
and
we
have
in
internal
initiatives
as
well
so
before
Pfizer
I
am
in
this
corporate
industry
for
quite
a
while
I
come
from
semiconductor
Hardware,
manufacturing
software
licensing
and
as
well
and
academician.
So
I
have
a
long
career.
C
Oh
hi
I'm
Sophia,
Lopez
I'm,
one
of
the
founders
of
collido,
a
web
3
infrastructure
company,
we've
been
very
focused
on
helping
Enterprises,
adopt
with
three
technology
over
the
last
five
years
prior
and
would
run
thousands
of
chains
across
industry.
So
but
Healthcare
is
a
special
place
in
my
heart
just
because
it
touches
all
of
our
lives
and
then
also
I
had
the
privilege
to
work
in
that
space.
I
was
at
IBM
for
10
years,
I'm
an
engineer
by
training,
but
I
actually
worked
for
two
and
a
half
years.
C
C
E
Amazon
now
for
about
three
years,
I
run
Global
business
development
for
our
Amazon,
managed,
blockchain
service
and
also
a
Quantum
Ledger
database.
So
we,
you
know
we're
seeing
a
lot
of
innovation
in
the
space,
especially
in
healthcare.
Digital
Transformations,
taking
place
across
the
industry,
and
a
lot
of
them
are
looking
to
adopt
blockchain
services,
and
you
know
so
I'll
be
happy
to
talk
to
you
guys
about
some
use
cases
that
we're
seeing
being
adopted.
A
Mm-Hmm
great
well
and
Charleston's
you
you're
the
last
one
went
over
the
mic.
I'll
kick
off
with
you
for
questions
sure,
as
we
mentioned
before,
we
even
get
into
the
blockchain
aspects
of
it
just
provide
briefly
to
the
audience
your
perspective
on
some
of
the
challenges
that
you
see:
healthcare,
industry,
Life
Sciences,
is
wise
and
then,
of
course,
share
with
everyone
else.
E
For
more
you
know,
information,
that's
can
be
anonymized
or
allowing
for
a
faster
adoption
from
a
customer
perspective.
So
in
decentralized
identity
is
one
area
where
that's
we're,
seeing
a
lot
of
interest
to
allow.
You
know
patients
to
store
their
data
and
also
have
control
over
the
data,
and
you
know
and
share
the
data
and
give
access
to
their
patient
data
across
public
chains.
So
that's
we're
seeing
a
lot
of
increased
usage
and
increased
adoption
in
that
space.
D
I
think
an
area
you
know
that's
a
simple,
but
in
a
consideration
that
should
be
emphasized
when
you're
starting
out
just
so
that
you
don't
get
stuck,
is
focusing
on
alignment.
So
the
first
part
of
alignment
is
getting
people
together
to
talk
about.
This
is
what
the
technology
can
do,
what
it
should
do.
What's
the
hype
around
it?
What's
you
know,
get
past
the
terminology
and
then
the
second
part
is
look
at
what
the
group
needs.
D
You
know
identify
the
basic
common
shared
services
that
you
need
focus
on,
creating
those
basic
shared
common
services
that
you
need
and
then
promoting
apps
that
are
built
in
those
consortiums
to
use
those.
You
know
shared
common
services
and
hopefully
that
sticks
with
everyone,
because,
as
you
elevate,
your
app
or
you
know,
go
forward,
you
want
people
to
have
trust,
so
anything
that's
built
in
a
devsecop
or
repeatable
manner.
That's
been
scanned
and
has
had
transparency.
You
know,
will
accelerate
software
development
and
confidence.
C
I
was
thinking
one
thing:
I
wanted
to
start
with
is
just
looking
at
least
from
the
shoes
of
the
the
folks
in
the
trenches.
So
you
know
over
the
last
decade,
if
you
were
talking
to
a
CIO
at
a
lot
of
healthcare
providers
who
got
hit
with
meaningful
use,
Accountable
Care,
Act,
moving
to
value-based
outcomes,
I'll
get
you
know,
issues
like
you
can't
have
the
same
person
with
a
chronic
care
condition
come
back
into
the
ER
within
30
days
or
you
won't
get
paid.
So
you
know
30
day.
C
C
Obviously,
moving
to
the
cloud
as
part
of
that
working
together
is
more
of
an
ecosystem,
because
you
have
population
Health,
you
have
Coordinated
Care,
so
you
can't
have
all
the
data
and
all
the
silos
like
traditionally
has
been
in
the
industry.
So
I
think
you
know
when
I
first
start
working
in
the
space.
Some
a
lot
of
cios
started
thinking.
This
is
a
good
time
to
retire
because
we've
got
these
regulations,
we've
got,
you
know,
fees
and
penalties.
C
If
we
don't
comply,
so
how
can
technology
help
us
and
and
you'd
see
often
in
a
lot
of
these
organizations?
You
know
they
were
buying
packaged
apps
and
didn't
really
have
the
skills
to
to
deal
with
some
of
these
new
challenges.
So
I
think
you
know
that
applies
to
now.
Looking
at
web
3
blockchain
digital
assets,
you
know,
how
do
you
get
the
skills
internally
to
do
this?
You
know
try
to
avoid
focusing
on
the
real
problems
of
bringing
multiple
parties
together
and
solving
issues
like
what
can
we
do?
C
B
Yeah
I
agree
with
all
of
them,
but
I
I
would
I
would
tackle
this
question
in
a
different
little
different
way.
Over
the
years
with
working
with
different
business
use
cases
and
blockchain
Technology,
we
categorized
all
the
problem
areas
into
three
groups
from
the
life
sciences
perspective.
One
is
from
the
Health
Data.
Second,
one
is
clinical
trial
and
third,
one
is
supply
chain.
When
it
comes
to
Health
Data,
it
sounds
easier
than
done.
B
It's
very
complex,
all
the
way
from
collecting
the
data,
storing
the
data
processing
the
data
and
who
owns
the
data
right.
We
just
I
was
listening
to
this
Kali
Health
now
and
everything
so
true.
The
problem
is
so
that
is
one
challenging
area.
We
can
use
blockchain
to
solve
some
of
it,
but
we
need
blessing
from
the
ecosystem
partners
and
all
of
it.
The
second
category
is
clinical
trial,
starting
from
the
discovery
phase,
all
the
way
to
marketing
post
marketing
server
real
world
evidence
everywhere,
I
see
where
the
technology
can
fit.
B
There
are
challenges,
but
there
are
opportunities
as
well
using
this
technology
and
supply
chain.
Everyone
knows
about
supply
chain,
it's
a
multiple
parties.
It's
the
goods
transferred
through
multiple
hands.
It's
a
low
hanging
fruit,
but
technology
adoption
wise.
There
are
many
challenges.
I
would
not
talk
about
this
one
like
multi-party,
bringing
everyone
on
board
and
Adoption
of
the
technology.
There
are
many
technology
providers,
but
who
is
buying
it
right?
Who
is
consuming
those
ones?
Those
are
the
main
areas
we
have
to
look
at
so
that
that
is
my
perspective.
A
B
Okay,
that's
an
interesting
question
yeah,
so
everyone
is
talking
about
digitization
and
digitalization.
So
I
got
to
understand
recently
that
there
are
two
different
concepts:
digitization
is
an
Automation
digitalization
and
changing
the
mindset,
as
well
as
the
automation,
so
from
from
the
digital
transformation
perspective.
Yes,
the
mindset
is
there:
the
culture
is
gradually
changing.
The
leaders
and
the
management
team
are
trying
to
put
together
teams
that
think
in
the
digital
transformation
way.
B
I
would
talk
specifically
about
blockchain,
so
there
are
many
Technologies
out
there.
I
would
compare
blockchain
with
Cloud
AI
ML
and
all
those
Technologies
cloud
and
AIML
got
their
adoption,
but
blockchain
from
the
Enterprise
perspective
struggling
little
bit
now.
That
is
because,
like
it's
a
multi-party
business,
it's
not
a
single
party.
I
cannot
simply
say
that
Pfizer
has
a
blockchain
network
running
its
own
node.
B
That
doesn't
make
sense,
so
we
are
not
not
yet
there,
but
what
what
we
are
planning
to
do
here
is
like
we
can
go
towards
public
blockchain
and
try
to
think
of
some
use
cases
that
we
can
go
alone
so
that
that
would
be
a
faster
route
to
adoption.
But
digital
transformation
is
pursuing
agile
methodology,
product
management.
All
these
things
are
coming
to
Enterprises.
So,
yes,
we
are
out
there.
Maybe
next,
two
three
years
all
organization
will
be
digital,
transparent
I
must
tell
this
thing.
B
Things
like
I
always
closely
observe
the
market,
the
workforce.
That
market
is
looking
for
right
now,
I
get
requirements
like
digitalization
of
sales
organization,
digitalization
of
quality
organization,
digitalization
of
marketing
organizations.
So
it's
good
to
see-
and
these
are
very
business
focused
with
digital
strategies.
So
our
organization
is
also
out
there.
C
One
comment
I
was
reflecting
when
you
were
speaking.
Is
you
know
if
you
just
look
at
digital
transformation
and
organizational
change?
There's
well-known
change
management,
specialist,
John
Cotter,
who
said
70
percent
of
organizational
change
initiatives
fail
so
a
lot
of
times.
People
will
look
at
the
technology
if
it's
not
the
technology,
it's
the
people
and
the
processes.
So
you
know
here's
a
number
of
principles
that
help
make.
You
know
what
are
principles
that
might
guarantee
a
better
chance
of
success
and
one
the
first
one
is.
C
You
need
a
burning
platform,
so
people
need
to
be
a
jump
from
where
they
are
because
their
feet
are
on
fire.
So
we
we
did
see
that
with
covid.
So
you
know,
we
collider
runs
networks
across
Industries
and
you
know
in
the
insurance
space,
which
is
probably
just
as
mired
in
compliance
and
Regulation
and
Legacy
systems
as
Healthcare.
They
told
us
that
their
digital
transformation
roadmaps
accelerated
by
decade
and
and
we
saw
that
there
and
they're
doing
really
interesting
projects,
projects
there's
actually
one
Consortium.
That's
over
100
years
old.
C
They
have
24
different
projects
going
on
industry
working
groups
with
the
across
life
and
annuities
Property
and
Casualty
reinsurance
doing
things
like
creating
a
master
death
record
in
the
U.S.
We
did.
You
know
when
covid
was
happening.
There
was
no
way.
You
know
people
you're,
asking
the
the
Widow,
whose
seven-year-old
husband
passed
away
to
take
a
paper
copy
of
the
death
certificate
to
the
bank
to
the
funeral
home
and
get
like
15
copies
of
these
in
middle
of
a
pandemic.
C
So
I
mean
that's
pretty
crazy,
so
Nationwide,
Prudential
and
others
said
we
need
to
come
together
to
get
solve
the
shared
data
problem
across
the
industry
and
that's
what
blockchain
is
really
good
for.
You
know
digital
Assets
Now
layer
on
incentives
with
tokens,
so
there's
a
healthcare
Network
that
many
of
you
are
familiar
with
called
synaptic
that
we
work
with
and
they
use
tokenized
incentives
really,
as
a
data
monetization
play
that
if
you
contribute
data
or
you
update
data,
you
get
paid,
you
avoid
the
tragedy.
C
The
commons
other
people
who
are
not
participating
not
contributing
they'll,
have
to
pay
to
subscribe
to
that
data
and
in
other
cases
we
see
instead
of
the
fungible
tokens
the
non-fungible.
So
documents
like
Powers
of
Attorney,
you
know
as
you're
digitizing
I
didn't
actually
know
the
difference
between
those
two
so
because
I
love
when
I
learned
something
new,
so
digitizing
these
very
paper-based
manual
processes.
You
know
now
you
can
represent
something
with
global
identity.
C
With
these
token
standards-
and
you
know,
there's
a
group
of
200
insurers,
we're
working
with
around
the
security
bonds
and
their
power
of
attorney
represented
with
nfts
or
things
like
credentialing
in
the
space
as
well.
So
it's
a
lot
of
interesting
developments,
but
a
lot
of
it's
trying
to
put
the
Easy
Button
into
technology
and
letting
people
focus
on
some
of
the
organizational
business
legal
issues
of
getting
multiple
parties
and
ecosystem
to
work
together
and
I.
Guess
in
multiple
people
mentioned
I.
C
Think
Enterprise
blockchain
started
thinking
about
solving
the
Frenemies,
as
Alan
said
in
our
prep
problem
competition.
You
know
this
shared
problem,
but
we're
also
seeing
a
lot
of
Enterprise
saying:
hey
I'm,
going
to
participate
in
a
dozen
or
more
use
cases,
so
I
need
a
web.
3
Gateway
I
might
run
a
node
in
one
network.
I
might
launch
my
own
solution
and
it's
really
more
of
just
a
decentralized
app
that
people
can
access,
it
might
be.
B2C
could
be
B2B.
C
D
So
I'm
going
to
just
talk
about
from
like
just
a
generalized
perspective
and
when
I
look
back
at
you
know,
open
source
projects
and
how
they
you
know
progress.
The
thing
that
sticks
to
me
is
the
accountability.
You
know,
how
do
we
add
accountability
to
make
these
systems
that
we
say
are
trustworthy
actually
trustworthy?
D
Just
because
it's
on
a
blockchain
doesn't
mean
it's.
You
know
awesome
and
I.
Look
at
you
know
existing
Industries.
You
know
they
do
know
your
customer,
they
do
the
proofing,
they
do
account
resolution
and
if
you
can
not
only
verify
that
the
transaction
on
your
blockchain
is
high
confidence,
maybe
not
perfect,
and
you
can
also
identify
that
the
people
behind
it
are
real
they're,
not
Bots
or
some
type
of
duplicate
accounts.
D
D
E
So
at
AWS
we
work
with
a
lot
of
customers
who
are
going
through
that
digital
transformation,
as
she
mentioned
earlier,
you
know.
During
covet
we
saw,
like
a
you
know,
giant
increase
in
customers
wanting
to
adopt
blockchain,
for
you
know,
covid
vaccine
tracking.
You
know
for
certifications
and
lots
about
two
or
three
projects,
and
we
also
see,
for
you
know,
supply
chain,
as
you
mentioned
earlier,
but
not
just
tracking
the
those
location
and
but
also
tracking
the
chain.
E
You
know
tracking
the
condition,
for
instance,
coveted
vaccines
require
you
know,
Cold
Storage,
so
you
know
we
see
all
we
saw
a
lot
of
implementations
of
you
know
using
temperature,
sensors
iot
devices
to
track
and
storing
all
that
information
on
on
the
blockchain.
So
that's
actually
led
to
a
lot
of
other
conversations
that
we're
having
with
traditional
you
know:
Healthcare
Life,
Sciences
companies
for
in
things
like
patient
consent,
tracking
and
other
other
use
cases.
E
Another
very
interesting
use
case
that
you
mentioned
was
for
incentivizing
patients
or
help
you
know
to
share
their
health
care
records
for
or
ensuring
that
they're
leveraging
or
taking
taking
their
doctor's
advice.
You
know
taking
their
medicines
and
offering
them
tokens
so
they
can
be
paid.
So
the
law
of
very
interesting
use
cases
that
we're
seeing-
and
it's
definitely
you
know,
as
in
the
healthcare
industry,
we
get
a
lot
of
you
know,
customers
asking
what
their
competitors
or
their
peers
are
doing,
and
you
know
they
want
to.
E
A
And
Charles
I'll
just
pull
on
that
thread
for
a
minute.
From
your
perspective,
AWS
we've
heard
quite
a
bit
so
far
about
things
like
governance
and
accountability
and
building
consortiums.
What
do
you
see
for
consortiums
and
Consortium
governance
coming
along
with
customers
as
a
Bedrock
to
their
to
their
blockchain
exploration
efforts.
E
Yeah
I
think
you
know
generally
what
we've
seen
is
we,
when
we
ask
customers
and
especially
customers,
reach
out
to
us
and
say,
hey
we're
interested
in
doing
a
blockchain
project.
I
mean
one
of
the
first
things
we
ask
is
what
which,
which
partners
are
you
interested
in
working
with?
Are
you
award
partners?
Are
you
expecting
to
join
the
Consortium
and
one
very
easy
to
indicator
of
whether
a
project
is
going
to
be
successful,
is
if
you
can
identify
one
or
two
partners
that
are
willing
to
join
you
in
that
POC?
E
If
you're,
not,
if
you
can't
find
somebody
you're
just
going
to
build
it
and
hope
they
come
most
likely,
it's
not
going
to
go
anywhere
and,
and
we've
also
seen
that
sometimes
it's
best
to
look
at
the
market
leaders
or
you
know,
companies
like
Pfizer,
you
know
who
are
who
have
already
and
loved
Market
presence,
and
there
are
lots
of
projects
in
that
space.
Regarding
things
like
you
know,
settling
pharmaceutical
claims-
and
you
know
pbrs,
which
is
a
pharmacy
benefit
management
and
so
working
with
those
large
those
organizations
were
able
to.
C
Yeah
it's
interesting.
There
are
a
lot
of
different
models
and
one
thing
I
didn't
mention
actually
in
the
intro,
so
I
was
at
IBM
and
launched
IBM
blockchain
platform,
actually
Sean
who's.
Here
we
worked
in
the
early
days
with
lots
of
different
models.
I
think
you
got
a
slide
of
a
lot
of
these
I.
Remember
was
we
were
observing
the
patterns,
so
I
mean
there
could
be
an
existing
Consortium.
C
So
we
see
that
in
some
Industries,
like
I
mentioned
Insurance
in
the
US,
there's
one
that's
over
100
years
old,
so
they
naturally
have
these
sort
of
working
groups
of
membership
and
then
they're
looking
at
how
can
they
sort
of
operationalize
going
from
you
know
a
lab
and
not
identifying
use
case
project
and
then
graduating
the
projects
up,
but
you
can
see
companies
who
form
a
new,
Co
or
basically
joint
venture
so
to
Charles.
Point
people
don't
like
joining
their
competitors
thing
they
want
to
be
equals
around
a
table.
C
So
we
we've
seen
some
models
of
that,
especially
in
like
the
first
generation
of
Enterprise
projects
and
the
cautions
there
are,
even
if
you're
well,
funded
by
Deep
Pockets,
who
are
each
of
the
members
you're,
basically
a
startup,
and
then
the
people
who
are
on
that
in
the
new
Co
need
to
think
and
act
like
a
startup.
You
need
to
be
very
focused
on
product
Market
fit.
C
So
so
those
are
some
different
models
and
then
there
are
people
who
you
know.
Have
the
industry
relationships
a
lot
of
this
or
existing
business
relationships
that
now
you're
digitally
transforming?
There
could
be
things
you
couldn't
do
before
that
you
could
do
now.
So
we
have
some
Industries
who
say:
we've
been
trying
to
solve
this
for
10
years,
and
now
we
finally
the
Technologies
here-
and
we
can
do
this,
so
there
could
be
situations
where
there
is
an
industry
solution.
Provider
and
people
are
subscribing
to
that
service.
C
C
You
know
product
or
efficiency
and
they're,
getting
a
lot
more
traction
and
you
don't
need
to
say,
hey,
there's
blockchain
inside,
because
it
should
get
to
that
across
many
of
these
use
cases
where
people
are
using
it
because
it
makes
sense
or
it
drives
some
additional
benefit,
but
not
because
of
the
technology
inside
and
I.
Think
that's
where
you
know
AI
that
started
30
plus
years
ago.
C
It's
gotten
to
you,
know
it's
woven
into
the
tapestry
of
a
lot
of
offerings
today,
but
it
took
a
while
to
get
there
and
I
think
blockchain's
actually
moving
and
web3
much
faster
than
that.
So
that's
the
good
news,
but
there's
a
lot
of
learnings
along
the
way,
which
is
why
it's
great
to
be
discussing
this
with
a
lot
of
Industry
leaders.
B
The
first
thing
for
us,
like
I,
will
talk
strictly
from
a
corporate
perspective
because
we
are
not
selling
service.
We
are
consumers
of
the
service
right.
So
it's
interesting
that
you
mentioned
that
we
don't
have
to
worry
about
funding.
Oh
yeah,
we
have
to
worry
about
funding.
So
for
the
first
thing
we
need
to
do
before
even
jumping
into
any
decision.
B
We
have
to
get
business
buy-in
because
business
is
the
one
who
funds
all
the
projects,
even
with
the
digital
Innovation.
The
operating
model
has
not
been
changed,
though.
The
mindset
is
changing
the
operating
model
to
change
the
operating
model.
It
will
take
a
while.
So
first
thing
is
we
get
the
business
buy-in
once
the
business
is
ready,
then
we
think
about
the
Consortium
building.
So
there
are
different
models
we
follow.
For
example,
we
can
partner
with
the
external
Consortium,
with
our
all
our
yours
and
all
our
actors
like
maybe
for
Pharma
industry.
B
It
would
be
wholesalers
or
the
dispensers
like
Walmart
Walgreens
in
the
U.S
I'm.
Sorry,
we
are
in
Ireland
I'm,
not
familiar
with
the
pharmacy
system,
but
that
is
one
thing.
For
example,
we
are
in
part
of
Pharma
Ledger,
where,
although
there
are
17
pharmaceutical
Industries,
we
are
part
of
that
group
as
well.
There
is
another
model
that
we
follow,
that
is
kind
of
startup
LED
model
that
is
a
chronicled
and
middle-ager
model,
so
that
startup
will
get
funding
from
The
Venture
capitals
and
then
the
startups
responsibilities
to
build
a
Consortium.
B
Then
the
startup
invites
us
to
join
the
Consortium,
but
remember
we
have
to
get
business
buy-in
to
join
that
one,
because
we
have
to
finance
our
participation
as
well.
So
that
is
another
model,
the
Third
Kind
of
model,
which
is
an
interesting
model
like
we
start
internally,
then
we
build
a
poc
in
a
small
scale.
Then
we
invite
our
peers
to
join
the
network
in
the
POC,
then
pilot,
then
then,
and
then
right
then
sell
it
in
all
these
models.
The
governance
is
very
important.
Actually
if
we
do
not
have
a
proper
governance.
B
The
first
question
we
get
from
our
peers
or
the
partners
who
has
right
to
decide
who
joins
your
network
right.
This
is
a
permission
Network
for
the
Enterprises.
So
then,
who
deploys
the
code
who
decide
the
code
change
management
like
Dev
seconds?
So
if
we
work
on
the
governance
from
the
gate
go
in
parallel,
so
by
the
time
we
reach
the
end
of
the
POC
and
we
are
ready
to
jump
in
the
pilot.
We
have
the
governance
model,
but
it
is
very
crucial
for
the
Enterprise
models.
B
The
last
model,
which
is
my
favorite
modem,
which
I
always
advocate
for
forget
about
all
the
Enterprise
blockchains
forget
about
all
the
permission.
Blockchains
and
everything
you
said
web3
is
advancing.
Why
can't
we
deploy
our
use
cases
using
public
blockchain?
We
are
talking
about
some
regulatory
aspects
of
it,
but
it
totally
depends
on
what
data.
Actually
you
are
putting
on
the
public
blockchain.
Why
can't
we
build
our
own
use
case
using
public
blockchain?
So
I
am
an
advocate
for
that
one,
but
as
I
mentioned
we
are,
we
have
to
get
business
buying.
B
We
are
not
yet
there,
but
we
are
pushing
for
some
public
blockchain
use
cases.
Interestingly
enough
that
there
is
a
decentralized
autonomous
organization
Towers
in
clinical
resources,
they
call
it
decentralized.
Science
I
think
we
were
talking
about
that.
So
Pfizer
has
expressed
interest
to
invest
in
Vita
Tau.
It's
a
public
news.
That's
why
I'm
at
the
liberty
of
discussing
it
with
the
audience,
so
that
mindset
is
there
it's
from
Pfizer
when
which
is
a
very
good
thing,
so
that
is
the
first
step
in
the
right
direction.
A
Excellent
good
feedback
and
I
think
we
have
about
five
minutes
left
on
our
schedule,
so
I
want
to
give
the
audience
a
chance.
I'm
sure
there
are
some
questions
Brewing
that
I
can
I,
don't
know
if
there's
a
mic
out
there,
if
there's
not
I'll,
be
happy
to
bring
it
over
to
you
for
any
questions
or
anything.
You
want
to
bring
up.
A
F
All
right,
hi,
I'm,
John,
gulchman
I
think
we've
all
met
but
I'm
with
polygon.
So
I
like
the
sound
of
the
public
blockchain
stuff,
but
I'm
curious
about
the
Dow
concept.
What
are
the,
what
would
be
the
kind
of
operations
of
the
Dow?
What
is
the
Dow
trying
to
achieve
I?
Think
Dows
were
a
great
use
case
also
for
Enterprises,
but
just
curious.
What
you're?
You
know
how
it's
working
with
Pfizer.
A
B
Is
this
apply
those
interests
to
invest
in
the
down
as
a
venture
capitalist
I
mentioned
it's
the
Pfizer
Ventures
interest,
so
we
are
investing
in
this
company
not
like.
We
are
participating
in
the
day-to-day
operations
or
buying
their
token
I.
Think
that
token
is
called
Vita
token
and
we
are
not
buying
that
token.
So
we
have
a
considerable
amount.
We
are
investing
there,
but
our
interest
is
in
clinical
resource
space,
which
is
the
decentralized
science
concept.
The
concept
of
this
clinical
research
is
like
we.
We
will
form
the
project
that
will
not
get
funding.
B
Otherwise,
there
are
many
research
initiatives,
but
they
die
soon
because
they
don't
get
the
funding.
The
intent
of
this
clinical
research
or
the
daos
in
clinical
research
and
decentralized
Science
in
general
is
to
provide
them
funding.
I
think
vitat
is
working
on
some
product
in
the
longevity
area
and
we
are
interested
in
that
one.
But
if
you
follow
the
Vita
Dows
paper,
the
white
paper,
the
the
use
case
is
very
interesting.
It
is
not
about.
In
the
token
you
buy,
to
get
the
Voting
Rights,
because
Dao
is
all
about
voting
rights
and
everything.
B
It's
not
only
the
token
you
buy,
but
it's
the
intellectual
property
as
well.
There
is
an
nft
angle,
two
years
the
intellectual
property
getting
generated
with
this
research
would
be
deployed
as
an
nft
and
you
can
monitor
monetize
it
in
the
marketplace,
selling
it
or
releasing
it.
So
that
is
another
interesting
angle,
so
we
are
interested
in
the
whole
concept,
so
we
are
invest.
We
expressed
interest
in
investing
in
this
organization,
make
sense.
Okay,
thanks
for
the
question.